找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Oral Antidiabetics; Jochen Kuhlmann,Walter Puls Book 1996 Springer-Verlag Berlin Heidelberg 1996 Antidiabetics.Biguanides.Diabetes.Diabete

[復(fù)制鏈接]
樓主: Inspection
31#
發(fā)表于 2025-3-26 21:47:02 | 只看該作者
Sulfonylureas: Physico-chemical Properties, Analytical Methods of Determination and Bioavailabilitytic drugs include acetohexamide, acetylcarbutamide, carboxytolbutamide, carbutamide, chlorpropamide, glibenclamide, glibornuride, gliclazide, glimepiride, glipizide, gliquidone, glisoxepide, metahexamide, tolazamide and tolbutamide. The structural formulas of some of the important antidiabetic agents are given in Fig. 1.
32#
發(fā)表于 2025-3-27 02:48:17 | 只看該作者
33#
發(fā)表于 2025-3-27 06:09:17 | 只看該作者
Clinical Pharmacology of Sulfonylureasion of insulin secretion. Sulfonylureas bind to receptor-like structures on the B cell, which may be closely linked to or be part of the potassium channels (. et al. 1987; . et al. 1988; . et al. 1990). The binding capacity of different sulfonylureas reflects their ability to stimulate insulin secretion.
34#
發(fā)表于 2025-3-27 13:26:43 | 只看該作者
35#
發(fā)表于 2025-3-27 15:33:44 | 只看該作者
36#
發(fā)表于 2025-3-27 18:21:56 | 只看該作者
Chemistry and Structure-Activity Relationships of Glucosidase Inhibitorse rational design of a lead compound, when the biochemical mechanism and the structure of the enzyme are well known. In the late 1960s, when we started to look for such potent and selective inhibitors, we had to choose the random screening approach, relying mainly on testing of extracts of the culture broths of microorganisms.
37#
發(fā)表于 2025-3-28 00:55:02 | 只看該作者
0171-2004 -threatening disease. This attitude needs to be changed because the complications asso- ciated with the adult form of diabetes affect almost every organ system. The high morbidity and mortality of non-insulin-dependent diabetes mellitus (NIDDM) suggest that current treatment strategies are unsatisfa
38#
發(fā)表于 2025-3-28 03:16:18 | 只看該作者
39#
發(fā)表于 2025-3-28 06:27:52 | 只看該作者
40#
發(fā)表于 2025-3-28 13:06:16 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 21:31
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
临夏市| 九江县| 玉林市| 剑河县| 恩平市| 鄂州市| 霍邱县| 新河县| 高淳县| 枞阳县| 象山县| 柳林县| 白河县| 固镇县| 永丰县| 讷河市| 乐山市| 醴陵市| 峨山| 冷水江市| 临江市| 炎陵县| 茌平县| 贵港市| 政和县| 应城市| 信阳市| 浦城县| 井陉县| 唐山市| 屏山县| 专栏| 长寿区| 荆州市| 虞城县| 乌鲁木齐县| 安化县| 和平县| 海晏县| 石楼县| 额尔古纳市|